Related Experiment Video
Updated: Jul 14, 2025

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
PANoptosis: Emerging mechanisms and disease implications
Zehong Qi1, Lili Zhu1, Kangkai Wang1
1Department of Pathophysiology, Key Laboratory of Sepsis Translational Medicine of Hunan, School of Basic Medical Science, Central South University, 410008 Changsha, Hunan, China.
Abstract:
PANoptosis, a unique new form of programmed cell death (PCD), is characterized by pyroptosis, apoptosis, and necroptosis, but it cannot be explained by pyroptosis, apoptosis or necroptosis alone. Assembly of the PANoptosome complex is a key feature of PANoptosis. To date, four kinds of PANoptosomes with distinct sensors and regulators have been defined, namely Z-DNA binding protein 1 (ZBP1) PANoptosome, absent in melanoma 2 (AIM2) PANoptosome, receptor-interacting protein kinase 1 (RIPK1) PANoptosome, and nucleotide-binding leucine-rich repeat-containing receptor 12 (NLRP12). Each PANoptosome contains three components: sensors for pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs), adaptors as connected bridges, and catalytic effectors or executioners. Mechanistically, different PAMPs or DAMPs are recognized by the sensors in a context-dependent manner, which initiates PANoptosome assembly through adaptors, and ultimately engages synchronous activation of pyroptosis, apoptosis, and necroptosis via different catalytic effectors. Resultantly, PANoptosis is emerged as a prospective and promising therapeutic target for various diseases. This review covers the accumulating evidence about the roles and mechanisms of PANoptosis in innate immunity and discusses the attractive prospect of manipulating PANoptosis as a new treatment for diseases.
Insights
PANoptosis, a programmed cell death (PCD) involving pyroptosis, apoptosis, and necroptosis, is regulated by PANoptosome complexes. Understanding PANoptosis offers new therapeutic targets for various diseases.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- PANoptosis is a novel form of programmed cell death (PCD) distinct from pyroptosis, apoptosis, and necroptosis.
- It is characterized by the assembly of a multi-protein complex known as the PANoptosome.
- Four types of PANoptosomes have been identified, each with specific sensors, adaptors, and catalytic effectors.
Purpose of the Study:
- To review the accumulating evidence on the roles and mechanisms of PANoptosis in innate immunity.
- To discuss the potential of manipulating PANoptosis as a therapeutic strategy for various diseases.
Main Methods:
- Literature review of studies on PANoptosis, PANoptosomes, and related cell death pathways.
- Analysis of the molecular mechanisms underlying PANoptosome assembly and activation.
- Discussion of the implications of PANoptosis in innate immunity and disease.
Main Results:
- PANoptosis involves the synchronous activation of pyroptosis, apoptosis, and necroptosis, mediated by distinct PANoptosome complexes.
- PANoptosomes are assembled through sensors recognizing pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs), linked by adaptors to catalytic effectors.
- Different PAMPs or DAMPs trigger specific PANoptosome assembly pathways in a context-dependent manner.
Conclusions:
- PANoptosis represents a crucial component of the innate immune response.
- The intricate mechanisms of PANoptosis and its regulation by PANoptosomes highlight its significance.
- Targeting PANoptosis presents a promising therapeutic avenue for treating a range of diseases.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Apoptosis
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Prosopagnosia
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

